Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Pension: 2017

  • Summit Therapeutics' Pension was N/A to $1,676 in Q1 2017 from the same period last year, while for Jan 2017 it was $1,676, marking a year-over-year change of. This contributed to the annual value of $1,808 for FY2017, which is N/A change from last year.
  • Summit Therapeutics' Pension amounted to $1,676 in Q1 2017.
  • Summit Therapeutics' 5-year Pension high stood at $1,676 for Q1 2017, and its period low was $1,676 during Q1 2017.
  • In the last 1 years, Summit Therapeutics' Pension had a median value of $1,676 in 2017 and averaged $1,676.